Astera Labs (ALAB) Financials

$94.46 +4.17 (+4.62%)

Closing price 05/20/2025 04:00 PM Eastern

Extended Trading

$93.20 -1.27 (-1.34%)

As of 08:58 AM Eastern

Annual Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-83	-26	-58
Consolidated Net Income / (Loss)	-83	-26	-58
Net Income / (Loss) Continuing Operations	-83	-26	-58
Total Pre-Tax Income	-82	-23	-58
Total Operating Income	-116	-29	-60
Total Gross Profit	303	80	59
Total Revenue	396	116	80
Operating Revenue	396	116	80
Total Cost of Revenue	94	36	21
Operating Cost of Revenue	94	36	21
Total Operating Expenses	419	109	119
Selling, General & Admin Expense	94	16	21
Marketing Expense	124	20	24
Research & Development Expense	201	73	74
Total Other Income / (Expense), net	34	6.55	2.61
Interest & Investment Income	34	6.55	2.61
Income Tax Expense	1.64	3.31	0.76
Basic Earnings per Share	($0.64)	($0.71)	($1.71)
Weighted Average Basic Shares Outstanding	131.26M	37.13M	34.17M
Diluted Earnings per Share	($0.64)	($0.71)	($1.71)
Weighted Average Diluted Shares Outstanding	131.26M	37.13M	34.17M
Weighted Average Basic & Diluted Shares Outstanding	162.15M	-	-

This table shows Astera Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Income / (Loss) Attributable to Common Shareholders	32	25	-7.59	-7.55	-93	14	-3.12	-20	-17
Consolidated Net Income / (Loss)	32	25	-7.59	-7.55	-93	14	-3.12	-20	-17
Net Income / (Loss) Continuing Operations	32	25	-7.59	-7.55	-93	14	-3.12	-20	-17
Total Pre-Tax Income	22	11	2.02	-14	-80	11	-0.25	-16	-17
Total Operating Income	11	0.14	-8.90	-24	-83	9.02	-1.98	-18	-19
Total Gross Profit	119	104	88	60	51	39	28	8.44	4.26
Total Revenue	159	141	113	77	65	51	37	11	18
Operating Revenue	159	141	113	77	65	51	37	11	18
Total Cost of Revenue	40	37	25	17	15	11	8.82	2.25	13
Operating Cost of Revenue	40	37	25	17	15	11	8.82	2.25	13
Total Operating Expenses	108	104	97	84	133	30	30	26	23
Selling, General & Admin Expense	22	25	23	22	24	5.36	3.95	3.10	3.53
Marketing Expense	22	23	23	22	56	5.00	5.51	5.10	4.39
Research & Development Expense	65	57	51	40	54	20	21	18	15
Total Other Income / (Expense), net	10	11	11	10	2.55	1.67	1.72	1.56	1.60
Interest & Investment Income	10	11	11	10	2.55	1.67	1.72	1.56	1.60
Income Tax Expense	-10	-14	9.61	-6.54	13	-3.63	2.87	3.95	0.12
Basic Earnings per Share	$0.19	$1.23	($0.05)	($0.05)	($1.77)	$0.41	($0.08)	($0.55)	($0.49)
Weighted Average Basic Shares Outstanding	163.19M	131.26M	156.83M	155.20M	52.53M	37.13M	37.47M	36.57M	35.83M
Diluted Earnings per Share	$0.18	$1.23	($0.05)	($0.05)	($1.77)	$0.41	($0.08)	($0.55)	($0.49)
Weighted Average Diluted Shares Outstanding	178.12M	131.26M	156.83M	155.20M	52.53M	37.13M	37.47M	36.57M	35.83M
Weighted Average Basic & Diluted Shares Outstanding	164.92M	162.15M	158.61M	156.66M	155.70M	0.00	-	-	-

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	35	-31	25
Net Cash From Operating Activities	137	-13	-36
Net Cash From Continuing Operating Activities	137	-13	-36
Net Income / (Loss) Continuing Operations	-83	-26	-58
Consolidated Net Income / (Loss)	-83	-26	-58
Depreciation Expense	3.15	1.78	0.81
Amortization Expense	-8.34	-1.62	-0.53
Non-Cash Adjustments To Reconcile Net Income	239	23	32
Changes in Operating Assets and Liabilities, net	-13	-9.68	-9.97
Net Cash From Investing Activities	-758	-18	-91
Net Cash From Continuing Investing Activities	-758	-18	-91
Purchase of Property, Plant & Equipment	-34	-2.76	-3.87
Purchase of Investments	-931	-126	-89
Sale and/or Maturity of Investments	209	111	2.00
Other Investing Activities, net	-1.41	0.00	0.00
Net Cash From Financing Activities	656	-0.50	152
Net Cash From Continuing Financing Activities	656	-0.50	152
Repurchase of Common Equity	-5.87	-1.62	-0.31
Issuance of Preferred Equity	0.00	0.00	150
Issuance of Common Equity	676	0.00	0.00
Other Financing Activities, net	-15	1.12	2.12
Cash Income Taxes Paid	7.79	2.48	0.00

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Change in Cash & Equivalents	6.95	-46	-295	-275	651	7.38	-56	-14	32
Net Cash From Operating Activities	11	40	64	30	3.65	14	-0.33	-23	-3.82
Net Cash From Continuing Operating Activities	11	40	64	30	3.65	14	-0.33	-23	-3.82
Net Income / (Loss) Continuing Operations	32	25	-7.59	-7.55	-93	14	-3.12	-20	-17
Consolidated Net Income / (Loss)	32	25	-7.59	-7.55	-93	14	-3.12	-20	-17
Depreciation Expense	1.13	0.97	0.85	0.72	0.61	0.54	0.48	0.41	0.36
Amortization Expense	-2.54	-3.47	-3.23	-1.07	-0.57	-0.59	-0.40	-0.23	-0.41
Non-Cash Adjustments To Reconcile Net Income	42	49	46	45	98	4.18	3.81	3.06	12
Changes in Operating Assets and Liabilities, net	-62	-31	27	-7.77	-1.79	-4.06	-1.10	-6.20	1.69
Net Cash From Investing Activities	-3.94	-91	-359	-302	-4.25	-5.96	-56	9.16	35
Net Cash From Continuing Investing Activities	-3.94	-91	-359	-302	-4.25	-5.96	-56	9.16	35
Purchase of Property, Plant & Equipment	-4.54	-15	-17	1.32	-3.42	-1.01	-0.74	-0.58	-0.44
Purchase of Investments	-191	-206	-379	-322	-23	-23	-76	-4.93	-22
Sale and/or Maturity of Investments	191	131	36	19	22	18	20	15	58
Net Cash From Financing Activities	0.39	5.65	0.95	-2.34	652	-1.06	0.64	-0.12	0.03
Net Cash From Continuing Financing Activities	0.39	5.65	0.95	-2.34	652	-1.06	0.64	-0.12	0.03
Repurchase of Common Equity	0.00	-1.07	-	-3.05	-1.76	-1.51	-0.02	-0.09	0.00
Issuance of Common Equity	0.00	4.16	-	-	672	-	-	-	0.00
Other Financing Activities, net	0.39	2.56	0.95	0.70	-19	0.45	0.66	-0.03	0.03

This table presents Astera Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023
Period end date	12/31/2024	12/31/2023
Total Assets	1,055	196
Total Current Assets	1,013	186
Cash & Equivalents	80	45
Short-Term Investments	835	104
Accounts Receivable	39	8.34
Inventories, net	43	24
Prepaid Expenses	17	4.06
Plant, Property, & Equipment, net	36	4.71
Total Noncurrent Assets	5.88	5.77
Other Noncurrent Operating Assets	5.88	5.77
Total Liabilities & Shareholders' Equity	1,055	196
Total Liabilities	90	39
Total Current Liabilities	87	35
Accounts Payable	27	6.34
Accrued Expenses	60	29
Total Noncurrent Liabilities	3.17	3.79
Other Noncurrent Operating Liabilities	3.17	3.79
Commitments & Contingencies	0.00	0.00
Redeemable Noncontrolling Interest	0.00	255
Total Equity & Noncontrolling Interests	965	-98
Total Preferred & Common Equity	965	-98
Total Common Equity	965	-98
Common Stock	1,173	27
Retained Earnings	-209	-125
Accumulated Other Comprehensive Income / (Loss)	0.43	0.26

This table presents Astera Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024
Total Assets	1,122	983	916	865
Total Current Assets	1,076	946	891	854
Cash & Equivalents	86	126	421	696
Short-Term Investments	838	761	410	105
Accounts Receivable	70	25	22	17
Inventories, net	51	24	29	30
Prepaid Expenses	30	8.99	9.45	6.73
Plant, Property, & Equipment, net	39	35	22	7.58
Total Noncurrent Assets	6.40	2.34	2.45	2.88
Other Noncurrent Operating Assets	6.40	2.34	2.45	2.88
Total Liabilities & Shareholders' Equity	1,122	983	916	865
Total Liabilities	80	93	70	56
Total Current Liabilities	77	88	64	46
Accounts Payable	30	19	15	11
Accrued Expenses	48	69	49	34
Total Noncurrent Liabilities	2.85	5.41	6.19	11
Other Noncurrent Operating Liabilities	2.85	5.41	6.19	11
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,042	890	845	809
Total Preferred & Common Equity	1,042	890	845	809
Total Common Equity	1,042	890	845	809
Common Stock	1,217	1,119	1,072	1,027
Retained Earnings	-177	-234	-226	-218
Accumulated Other Comprehensive Income / (Loss)	2.03	4.43	-0.35	-0.06

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	242.24%	44.97%	0.00%
EBITDA Growth	-313.27%	51.03%	0.00%
EBIT Growth	-293.48%	51.00%	0.00%
NOPAT Growth	-293.48%	51.00%	0.00%
Net Income Growth	-217.71%	55.00%	0.00%
EPS Growth	9.86%	58.48%	0.00%
Operating Cash Flow Growth	1,174.83%	64.58%	0.00%
Free Cash Flow Firm Growth	-329.86%	0.00%	0.00%
Invested Capital Growth	522.43%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	1,696.44%	0.00%	0.00%
Profitability Metrics	-	-	-
Gross Margin	76.38%	68.94%	73.47%
EBITDA Margin	-30.60%	-25.34%	-75.01%
Operating Margin	-29.29%	-25.47%	-75.36%
EBIT Margin	-29.29%	-25.47%	-75.36%
Profit (Net Income) Margin	-21.05%	-22.68%	-73.05%
Tax Burden Percent	102.01%	114.42%	101.33%
Interest Burden Percent	70.46%	77.80%	95.66%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-277.24%	-509.01%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-276.83%	-501.49%	0.00%
Return on Net Nonoperating Assets (RNNOA)	262.37%	475.65%	0.00%
Return on Equity (ROE)	-14.87%	-33.36%	0.00%
Cash Return on Invested Capital (CROIC)	-421.87%	-709.01%	0.00%
Operating Return on Assets (OROA)	-18.56%	-15.03%	0.00%
Return on Assets (ROA)	-13.34%	-13.38%	0.00%
Return on Common Equity (ROCE)	-11.49%	20.70%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-8.65%	26.87%	0.00%
Net Operating Profit after Tax (NOPAT)	-81	-21	-42
NOPAT Margin	-20.50%	-17.83%	-52.75%
Net Nonoperating Expense Percent (NNEP)	-0.41%	-7.51%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-8.42%	21.13%	-
Cost of Revenue to Revenue	23.62%	31.06%	26.53%
SG&A Expenses to Revenue	23.79%	13.75%	25.99%
R&D to Revenue	50.68%	63.39%	92.29%
Operating Expenses to Revenue	105.67%	94.41%	148.83%
Earnings before Interest and Taxes (EBIT)	-116	-29	-60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-121	-29	-60
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	21.77	0.00	0.00
Price to Tangible Book Value (P/TBV)	21.77	0.00	0.00
Price to Revenue (P/Rev)	53.01	6.16	8.92
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	397.91	100.90	0.00
Enterprise Value to Revenue (EV/Rev)	50.70	7.07	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	147.02	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.95	-0.95	0.00
Leverage Ratio	1.11	1.25	0.00
Compound Leverage Factor	0.79	0.97	0.00
Debt to Total Capital	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	162.06%	0.00%
Common Equity to Total Capital	100.00%	-62.06%	0.00%
Debt to EBITDA	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	141.30	11.13	0.00
Noncontrolling Interest Sharing Ratio	22.73%	162.06%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	11.71	5.30	0.00
Quick Ratio	11.01	4.49	0.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-124	-29	0.00
Operating Cash Flow to CapEx	399.11%	-460.56%	-926.88%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.63	0.59	0.00
Accounts Receivable Turnover	16.81	13.89	0.00
Inventory Turnover	2.78	1.49	0.00
Fixed Asset Turnover	19.64	24.57	0.00
Accounts Payable Turnover	5.63	5.68	0.00
Days Sales Outstanding (DSO)	21.71	26.27	0.00
Days Inventory Outstanding (DIO)	131.25	244.52	0.00
Days Payable Outstanding (DPO)	64.85	64.31	0.00
Cash Conversion Cycle (CCC)	88.12	206.48	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	50	8.11	0.00
Invested Capital Turnover	13.52	28.55	0.00
Increase / (Decrease) in Invested Capital	42	8.11	0.00
Enterprise Value (EV)	20,094	819	0.00
Market Capitalization	21,008	713	713
Book Value per Share	$6.08	($2.63)	$0.00
Tangible Book Value per Share	$6.08	($2.63)	$0.00
Total Capital	965	157	0.00
Total Debt	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-914	-149	0.00
Capital Expenditures (CapEx)	34	2.76	3.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	12	1.42	0.00
Debt-free Net Working Capital (DFNWC)	926	151	0.00
Net Working Capital (NWC)	926	151	0.00
Net Nonoperating Expense (NNE)	2.17	5.61	16
Net Nonoperating Obligations (NNO)	-914	-149	0.00
Total Depreciation and Amortization (D&A)	-5.19	0.16	0.28
Debt-free, Cash-free Net Working Capital to Revenue	3.06%	1.22%	0.00%
Debt-free Net Working Capital to Revenue	233.78%	130.17%	0.00%
Net Working Capital to Revenue	233.78%	130.17%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.64)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	131.26M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.64)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	131.26M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	162.15M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-81	-21	-42
Normalized NOPAT Margin	-20.50%	-17.83%	-52.75%
Pre Tax Income Margin	-20.64%	-19.82%	-72.09%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-7.03%	-6.16%	-0.54%

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	144.33%	179.32%	206.23%	619.03%	269.44%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	111.90%	-126.24%	-494.20%	-41.67%	-336.85%	0.00%	0.00%	0.00%	0.00%
EBIT Growth	113.60%	-98.40%	-349.97%	-38.23%	-338.35%	0.00%	0.00%	0.00%	0.00%
NOPAT Growth	128.47%	-97.25%	2,521.10%	-38.23%	-338.35%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	134.22%	72.52%	-143.05%	62.28%	-432.80%	0.00%	0.00%	0.00%	0.00%
EPS Growth	110.17%	200.00%	37.50%	90.91%	-261.22%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	187.62%	175.73%	19,114.37%	229.84%	195.63%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	-41.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	1,480.36%	522.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	13.00%	24.77%	47.15%	17.76%	0.00%	36.79%	245.51%	-39.49%	0.00%
EBITDA Q/Q Growth	519.02%	79.12%	54.34%	70.21%	0.00%	572.87%	89.11%	8.14%	0.00%
EBIT Q/Q Growth	7,736.81%	101.62%	63.46%	70.65%	0.00%	556.25%	88.78%	6.94%	0.00%
NOPAT Q/Q Growth	4,872.39%	-99.01%	296.60%	70.65%	0.00%	973.08%	88.78%	6.94%	0.00%
Net Income Q/Q Growth	28.75%	425.47%	-0.62%	91.89%	0.00%	558.55%	84.38%	-14.61%	0.00%
EPS Q/Q Growth	-85.37%	2,560.00%	0.00%	97.18%	0.00%	612.50%	85.45%	-12.24%	0.00%
Operating Cash Flow Q/Q Growth	-73.54%	-37.48%	113.02%	716.35%	0.00%	4,411.08%	98.55%	-501.26%	0.00%
Free Cash Flow Firm Q/Q Growth	-120.93%	-237.00%	198.07%	52.19%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	131.37%	1,696.44%	-80.28%	92.84%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	74.89%	74.03%	77.71%	77.88%	77.42%	77.26%	76.11%	78.96%	24.11%
EBITDA Margin	6.19%	-1.67%	-9.97%	-32.14%	-127.06%	17.77%	-5.14%	-163.14%	-107.46%
Operating Margin	7.08%	0.10%	-7.87%	-31.68%	-127.14%	17.86%	-5.35%	-164.79%	-107.15%
EBIT Margin	7.08%	0.10%	-7.87%	-31.68%	-127.14%	17.86%	-5.35%	-164.79%	-107.15%
Profit (Net Income) Margin	19.96%	17.52%	-6.71%	-9.82%	-142.50%	28.36%	-8.46%	-187.16%	-98.81%
Tax Burden Percent	146.52%	230.92%	-376.64%	53.58%	115.65%	133.95%	1,234.78%	124.57%	100.71%
Interest Burden Percent	192.44%	7,431.94%	-22.66%	57.84%	96.92%	118.56%	12.80%	91.17%	91.57%
Effective Tax Rate	-46.52%	-130.92%	476.64%	0.00%	0.00%	-33.95%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	81.89%	3.19%	0.00%	0.00%	0.00%	341.39%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	80.11%	-1.40%	0.00%	0.00%	0.00%	339.89%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-74.74%	1.32%	0.00%	0.00%	0.00%	-322.37%	0.00%	0.00%	0.00%
Return on Equity (ROE)	7.15%	4.51%	0.00%	0.00%	0.00%	19.02%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	-247.62%	-421.87%	0.00%	0.00%	0.00%	-354.50%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	3.49%	0.06%	0.00%	0.00%	0.00%	10.53%	0.00%	0.00%	0.00%
Return on Assets (ROA)	9.85%	11.10%	0.00%	0.00%	0.00%	16.73%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	7.15%	3.49%	0.00%	0.00%	0.00%	-11.80%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	3.97%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	17	0.33	34	-17	-58	12	-1.38	-12	-13
NOPAT Margin	10.37%	0.24%	29.63%	-22.18%	-89.00%	23.92%	-3.75%	-115.35%	-75.01%
Net Nonoperating Expense Percent (NNEP)	1.77%	4.58%	-9.27%	2.29%	-8.71%	1.50%	0.00%	0.00%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.59%	0.03%	-	-	-	-12.37%	-	-	-
Cost of Revenue to Revenue	25.11%	25.97%	22.29%	22.12%	22.58%	22.74%	23.89%	21.04%	75.89%
SG&A Expenses to Revenue	13.72%	17.69%	20.22%	28.67%	37.42%	10.60%	10.69%	28.96%	19.96%
R&D to Revenue	40.49%	40.06%	44.80%	52.17%	82.07%	38.91%	55.85%	167.10%	86.43%
Operating Expenses to Revenue	67.82%	73.92%	85.57%	109.57%	204.55%	59.40%	81.46%	243.75%	131.26%
Earnings before Interest and Taxes (EBIT)	11	0.14	-8.90	-24	-83	9.02	-1.98	-18	-19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	9.87	-2.36	-11	-25	-83	8.98	-1.90	-17	-19
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.29	21.77	9.23	11.15	1.82	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	9.29	21.77	9.23	11.15	1.82	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	19.73	53.01	0.00	0.00	0.00	6.16	0.00	0.00	0.00
Price to Earnings (P/E)	233.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	74.90	397.91	2,604.21	602.55	90.30	100.90	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	17.84	50.70	0.00	0.00	0.00	7.07	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	60.97	147.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.93	-0.95	-1.00	-0.98	-0.99	-0.95	0.00	0.00	0.00
Leverage Ratio	1.07	1.11	1.11	1.08	1.07	1.25	0.00	0.00	0.00
Compound Leverage Factor	2.07	82.83	-0.25	0.63	1.04	1.48	0.00	0.00	0.00
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	162.06%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	-62.06%	0.00%	0.00%	0.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	73.77	141.66	53.38	81.10	16.16	11.77	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	22.73%	0.00%	0.00%	0.00%	162.06%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	13.92	11.71	10.74	13.91	18.74	5.30	0.00	0.00	0.00
Quick Ratio	12.87	11.01	10.36	13.32	17.95	4.49	0.00	0.00	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-93	-42	31	-31	-65	0.00	0.00	0.00	0.00
Operating Cash Flow to CapEx	231.42%	257.01%	380.36%	0.00%	106.66%	1,424.23%	-45.38%	-3,993.39%	-869.93%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.63	0.00	0.00	0.00	0.59	0.00	0.00	0.00
Accounts Receivable Turnover	11.34	16.81	0.00	0.00	0.00	13.89	0.00	0.00	0.00
Inventory Turnover	2.95	2.78	0.00	0.00	0.00	1.49	0.00	0.00	0.00
Fixed Asset Turnover	20.85	19.64	0.00	0.00	0.00	24.57	0.00	0.00	0.00
Accounts Payable Turnover	5.80	5.63	0.00	0.00	0.00	5.68	0.00	0.00	0.00
Days Sales Outstanding (DSO)	32.20	21.71	0.00	0.00	0.00	26.27	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	123.77	131.25	0.00	0.00	0.00	244.52	0.00	0.00	0.00
Days Payable Outstanding (DPO)	62.91	64.85	0.00	0.00	0.00	64.31	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	93.06	88.12	0.00	0.00	0.00	206.48	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	117	50	2.81	14	7.39	8.11	0.00	0.00	0.00
Invested Capital Turnover	7.90	13.52	0.00	0.00	0.00	14.27	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	109	42	2.81	14	7.39	0.00	0.00	0.00	0.00
Enterprise Value (EV)	8,751	20,094	7,320	8,590	668	819	0.00	0.00	0.00
Market Capitalization	9,676	21,008	8,207	9,421	1,469	713	713	713	713
Book Value per Share	$6.42	$6.08	$5.68	$5.43	$15.40	($2.63)	$0.00	$0.00	$0.00
Tangible Book Value per Share	$6.42	$6.08	$5.68	$5.43	$15.40	($2.63)	$0.00	$0.00	$0.00
Total Capital	1,042	965	890	845	809	157	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-925	-914	-887	-831	-801	-149	0.00	0.00	0.00
Capital Expenditures (CapEx)	4.54	15	17	-1.32	3.42	1.01	0.74	0.58	0.44
Debt-free, Cash-free Net Working Capital (DFCFNWC)	74	12	-29	-3.82	7.46	1.42	0.00	0.00	0.00
Debt-free Net Working Capital (DFNWC)	999	926	858	827	809	151	0.00	0.00	0.00
Net Working Capital (NWC)	999	926	858	827	809	151	0.00	0.00	0.00
Net Nonoperating Expense (NNE)	-15	-24	41	-9.50	35	-2.24	1.74	7.67	4.21
Net Nonoperating Obligations (NNO)	-925	-914	-887	-831	-801	-149	0.00	0.00	0.00
Total Depreciation and Amortization (D&A)	-1.42	-2.50	-2.38	-0.35	0.05	-0.05	0.08	0.18	-0.05
Debt-free, Cash-free Net Working Capital to Revenue	15.05%	3.06%	0.00%	0.00%	0.00%	1.22%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	203.59%	233.78%	0.00%	0.00%	0.00%	130.17%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	203.59%	233.78%	0.00%	0.00%	0.00%	130.17%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.19	$1.23	($0.05)	($0.05)	($1.77)	$0.41	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	163.19M	131.26M	156.83M	155.20M	52.53M	37.13M	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$0.18	$1.23	($0.05)	($0.05)	($1.77)	$0.41	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	178.12M	131.26M	156.83M	155.20M	52.53M	37.13M	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	164.92M	162.15M	158.61M	156.66M	155.70M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	7.90	0.10	-6.23	-17	-58	6.31	-1.38	-12	-13
Normalized NOPAT Margin	4.95%	0.07%	-5.51%	-22.18%	-89.00%	12.50%	-3.75%	-115.35%	-75.01%
Pre Tax Income Margin	13.62%	7.58%	1.78%	-18.33%	-123.22%	21.17%	-0.69%	-150.24%	-98.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	9.93%	-7.03%	0.00%	0.00%	0.00%	-6.16%	0.00%	0.00%	0.00%

Frequently Asked Questions About Astera Labs' Financials

When does Astera Labs's fiscal year end?

According to the most recent income statement we have on file, Astera Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Astera Labs' net income changed over the last 2 years?

Astera Labs' net income appears to be on an upward trend, with a most recent value of -$83.42 million in 2024, rising from -$58.35 million in 2022. The previous period was -$26.26 million in 2023. See Astera Labs' forecast for analyst expectations on what’s next for the company.

What is Astera Labs's operating income?

Astera Labs's total operating income in 2024 was -$116.07 million, based on the following breakdown:

Total Gross Profit: $302.70 million
Total Operating Expenses: $418.77 million

How has Astera Labs revenue changed over the last 2 years?

Over the last 2 years, Astera Labs' total revenue changed from $79.87 million in 2022 to $396.29 million in 2024, a change of 396.2%.

How much debt does Astera Labs have?

Astera Labs' total liabilities were at $89.71 million at the end of 2024, a 130.8% increase from 2023, and a 130.8% increase since 2023.

How much cash does Astera Labs have?

In the past 1 years, Astera Labs' cash and equivalents has ranged from $45.10 million in 2023 to $79.55 million in 2024, and is currently $79.55 million as of their latest financial filing in 2024.

How has Astera Labs' book value per share changed over the last 2 years?

Over the last 2 years, Astera Labs' book value per share changed from 0.00 in 2022 to 6.08 in 2024, a change of 608.3%.

Related Companies

This page (NASDAQ:ALAB) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astera Labs (ALAB) Financials

Frequently Asked Questions About Astera Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astera Labs (ALAB) Financials

Annual Income Statements for Astera Labs

Quarterly Income Statements for Astera Labs

Annual Cash Flow Statements for Astera Labs

Quarterly Cash Flow Statements for Astera Labs

Annual Balance Sheets for Astera Labs

Quarterly Balance Sheets for Astera Labs

Annual Metrics And Ratios for Astera Labs

Quarterly Metrics And Ratios for Astera Labs

Frequently Asked Questions About Astera Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools